Tandem Diabetes Care (TNDM) Share-based Compensation (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Share-based Compensation for 14 consecutive years, with $15.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation fell 38.61% year-over-year to $15.7 million; the trailing twelve-month figure through Jun 2026 stood at $72.7 million (down 31.19% YoY), and the FY2025 full-year result was $92.4 million, down 8.88% from the prior year.
• Share-based Compensation grew to $15.7 million in Q2 2026 per TNDM's latest filing, from $15.7 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $107.5 million in Q1 2022 and bottomed at $465000.0 in Q3 2022.
• Historically, Share-based Compensation has averaged $23.7 million across 5 years, with a median of $21.6 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation tumbled 97.04% in 2022, then soared 4360.43% in 2023.
• Over 5 years, Share-based Compensation stood at $3.0 million in 2022, then jumped by 652.27% to $22.7 million in 2023, then grew by 23.86% to $28.2 million in 2024, then dropped by 28.6% to $20.1 million in 2025, then dropped by 21.73% to $15.7 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $15.7 million, $15.7 million, and $20.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.